Article
Anakinra treatment in drug-resistant Behcet's disease: a case series.
Clinical rheumatology - 1 Jul 2015
Cantarini Luca, Vitale Antonio, Scalini Perla, Dinarello Charles A, Rigante Donato, Franceschini Rossella, Simonini Gabriele, Borsari Giulia, Caso Francesco, Lucherini Orso Maria, Frediani Bruno, Bertoldi Ilaria, Punzi Leonardo, Galeazzi Mauro, Cimaz Rolando
Abstract excerpt
The study objective was to report treatment with an interleukin (IL)-1 receptor antagonist, anakinra, in patients with multiorgan Behcet's disease (BD). Comparison of clinical manifestations, previous treatments, markers of inflammation, concomitant medications, treatment regimen modifications, relapses, and adverse events before and during anakinra administration among patients with BD were evaluated. Nine BD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.